Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Si-Bone Inc (SIBN)

Si-Bone Inc (SIBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance GlobeNewswire - Mon Feb 23, 3:09PM CST

Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025 Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE,...

SIBN : 12.99 (+1.56%)
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026 GlobeNewswire - Tue Feb 17, 3:30PM CST

SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 12.99 (+1.56%)
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026 GlobeNewswire - Mon Feb 2, 3:30PM CST

SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 12.99 (+1.56%)
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 GlobeNewswire - Mon Jan 12, 8:00AM CST

SANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 12.99 (+1.56%)
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 GlobeNewswire - Tue Nov 18, 2025

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating...

SIBN : 12.99 (+1.56%)
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance GlobeNewswire - Mon Nov 10, 2025

Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are...

SIBN : 12.99 (+1.56%)
SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 GlobeNewswire - Mon Oct 20, 2025

SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results...

SIBN : 12.99 (+1.56%)
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025 GlobeNewswire - Tue Aug 26, 2025

SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating...

SIBN : 12.99 (+1.56%)
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance GlobeNewswire - Mon Aug 4, 2025

Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7% U.S. revenue of $46.4 million, representing...

SIBN : 12.99 (+1.56%)
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 GlobeNewswire - Tue Jul 29, 2025

SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating...

SIBN : 12.99 (+1.56%)

Barchart Exclusives

What's the Connection Between the US War on Iran, Fuel, Fertilizer, and Food Prices? (Part 2) Barchart - 37 minutes ago
Though global markets can be independent of each other, there are connections running throughout the commodity complex. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.